Scientific American
Peter Gilbert, research professor of biostatistics and a biostatistician at Fred Hutch, comments on assessing safety and efficacy after an Emergency Use Authorization has been approved. Gilbert has helped design clinical trials for the leading U.S. vaccine candidates.
Category